Germacrone inhibits early stages of influenza virus infection

Antiviral Research

Volumn 100, Issue 3, 2013, Pages 578-588

  Liao, Qingjiao ^a   Qian, Zhengxu ^a   Liu, Rui ^a   An, Liwei ^a   Chen, Xulin ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

Germacrone; Influenza virus; Inhibitor

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ANTIVIRUS AGENT; ESSENTIAL OIL; GERMACRONE; OSELTAMIVIR; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; HERBACEOUS AGENT; INHIBITOR; SESQUITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CURCUMA; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA A (H3N2); INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RHIZOME; RNA SYNTHESIS; TREATMENT DURATION; VIRUS ATTACHMENT; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; VIRUS TRANSMISSION; ANIMAL; CELL LINE; CHICK EMBRYO; COMPARATIVE STUDY; DOG; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; GERMFREE ANIMAL; HUMAN; INFLUENZA VIRUS A H3N2; LUNG; MDCK CELL; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; PHYTOTHERAPY; VIROLOGY; VIRUS CULTURE; DRUG EFFECTS; MDCK CELL LINE; ORTHOMYXOVIRIDAE INFECTIONS;

CURCUMA; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MUS; ORTHOMYXOVIRIDAE;

GERMACRONE; INFLUENZA VIRUS; INHIBITOR;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHICK EMBRYO; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; LUNG; MADIN DARBY CANINE KIDNEY CELLS; MICE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; PHYTOTHERAPY; RIBAVIRIN; SESQUITERPENES, GERMACRANE; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRUS ATTACHMENT; VIRUS CULTIVATION; VIRUS REPLICATION;

EID: 84886743601     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.09.021     Document Type: Article

References (27)

1. A.F. Barrero, M.M. Herrador, P. Arteaga, and J.V. Catalan Germacrone: occurrence, synthesis, chemical transformations and biological properties Nat. Prod. Commun. 3 2008 567 576
2. M.C. Berenbaum What is synergy? Pharmacol. Rev. 41 1989 93 141 (Pubitemid 20019599)
3. C. Chaipan, D. Kobasa, S. Bertram, I. Glowacka, I. Steffen, T.S. Tsegaye, M. Takeda, T.H. Bugge, S. Kim, Y. Park, A. Marzi, and S. Pohlmann Proteolytic activation of the 1918 influenza virus hemagglutinin J. Virol. 83 2009 3200 3211
4. P. Claeson, U. Pongprayoon, T. Sematong, P. Tuchinada, V. Reutrakul, P. Soontornsaratune, and W.C. Taylor Non-phenolic linear diarylheptanoids from curcuma xanthorrhiza: a novel type of topical anti-inflammatory agents: structure-activity relationship Planta. Med. 62 1996 236 240
5. E. De Clercq Antivirals and antiviral strategies Nat. Rev. Microbiol. 2 2004 704 720 (Pubitemid 39206268)
6. E. De Clercq Antiviral agents active against influenza A viruses Nat. Rev. Drug. Discov. 5 2006 1015 1025 (Pubitemid 44835128)
7. P. Dohare, P. Garg, U. Sharma, N.R. Jagannathan, and M. Ray Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model BMC Complement. Altern. Med. 8 2008 55
8. Y. Furuta, K. Takahashi, M. Kuno-Maekawa, H. Sangawa, S. Uehara, K. Kozaki, N. Nomura, H. Egawa, and K. Shiraki Mechanism of action of T-705 against influenza virus Antimicrob. Agents. Chemother. 49 2005 981 986 (Pubitemid 40327713)
9. B.S. Kamps, C. Hoffmann, and W. Preiser Influenza Report 2006 2006 225
10. Y. Li, J.M. Wo, Q. Liu, X. Li, and R.C. Martin Chemoprotective effects of curcuma aromatica on esophageal carcinogenesis Ann. Surg. Oncol. 16 2009 515 523
11. H. Makabe, N. Maru, A. Kuwabara, T. Kamo, and M. Hirota Anti-inflammatory sesquiterpenes from curcuma zedoaria Nat. Prod. Res. 20 2006 680 685 (Pubitemid 43878619)
12. M.N. Matrosovich, T.Y. Matrosovich, T. Gray, N.A. Roberts, and H.D. Klenk Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium J. Virol. 78 2004 12665 12667 (Pubitemid 39458784)
13. H. Matsuda, K. Ninomiya, T. Morikawa, and M. Yoshikawa Inhibitory effect and action mechanism of sesquiterpenes from zedoariae rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury Bioorg. Med. Chem. Lett. 8 1998 339 344 (Pubitemid 28072703)
14. J.L. McKimm-Breschkin Resistance of influenza viruses to neuraminidase inhibitors - a review Antiviral. Res. 47 2000 1 17 (Pubitemid 30621392)
15. N.A. Molinari, I.R. Ortega-Sanchez, M.L. Messonnier, W.W. Thompson, P.M. Wortley, E. Weintraub, and C.B. Bridges The annual impact of seasonal influenza in the US: measuring disease burden and costs Vaccine 25 2007 5086 5096 (Pubitemid 46879994)
16. A. Moscona Neuraminidase inhibitors for influenza N. Engl. J. Med. 353 2005 1363 1373 (Pubitemid 41362704)
17. F.C. Odds Synergy, antagonism and what the chequerboard puts between them J. Antimicrob. Chemother. 52 2003 1 (Pubitemid 36850074)
18. J.S. Peiris, L.L. Poon, and Y. Guan Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans J. Clin. Virol. 45 2009 169 173
19. L.H. Pinto, L.J. Holsinger, and R.A. Lamb Influenza virus M2 protein has ion channel activity Cell 69 1992 517 528
20. M. Rajik, F. Jahanshiri, A.R. Omar, A. Ideris, S.S. Hassan, and K. Yusoff Identification and characterisation of a novel antiviral peptide against avian influenza virus H9N2 Virol. J. 6 2009 74
21. L.J. Reed, and H. Muench A simple method of estimating fifty per cent endpionts Am. J. Epidemiol. 27 1938 493 497
22. M.B. Rothberg, S.D. Haessler, and R.B. Brown Complications of viral influenza Am. J. Med. 121 2008 258 264 (Pubitemid 351417852)
23. J.M. Song, K.H. Lee, and B.L. Seong Antiviral effect of catechins in green tea on influenza virus Antiviral. Res. 68 2005 66 74
24. Z. Wan, Y. Lu, Q. Liao, Y. Wu, and X. Chen Fangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processing PLoS One 7 2012 e39225
25. D.M. Weinstock, and G. Zuccotti Adamantane resistance in influenza A JAMA 295 2006 934 936
26. N.T. Wetherall, T. Trivedi, J. Zeller, C. Hodges-Savola, J.L. McKimm-Breschkin, M. Zambon, and F.G. Hayden Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network J. Clin. Microbiol. 41 2003 742 750 (Pubitemid 36184190)
27. Z. Zhong, X. Chen, W. Tan, Z. Xu, K. Zhou, T. Wu, L. Cui, and Y. Wang Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis Eur. J. Pharmacol. 667 2011 50 55